Price transparency continues to plague healthcare, as this new report from Castlight Health suggests.
Healthcare price transparency continues to be an ongoing struggle for payers and patients. While grocery stores service competitive prices for a box of cereal, the variability in prices for the same healthcare service sees a huge differential. A new report released by Castlight Health underscores this problem, with the pricing of mammograms in 30 largest cities in the United States as a case study.
For the study, Castlight Health examined the pricing of OB/GYN follow-up visits, preventative gynecological exams, mammograms, and HPV tests across states, using medical claims data. Additionally, provider information, provider rate sheets (payer-provider negotiated rates), and some publicly available information was included in the data set. Employee out-of-pocket cost added to the amount paid by the employer was defined as the price of a service.
The results were astounding—a 44x variation in the cost of a mammogram across the 30 cities, ranging from $43 (Sarasota-Bradenton, FL) to $1898 (NY, Northern NJ, Long Island). The analysis notes that women in the larger metropolitan areas are charged exorbitantly higher—with huge price variations—for an important preventive test. While some cities included in the study (including Holland, MI; Sharon, PA; Columbia, MO; Daytona Beach, FL) had no price variation, some saw a variation that ranged from 2-fold (including Pittsburgh, PA and New Orleans, LA) to nearly 21-fold (Dallas-Fort Worth, TX) in the same city.
According to Jonathan Rende, chief research and development officer at Castlight Health, these findings speak to our broken healthcare system. “We’ve seen over the years that women are bigger consumers of health care than men in general and we wanted to drill into some of the more common services and see how those varied,” Rende said when speaking about their study.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Lack of Mutations Associated With Favorable Prognosis in MPN-U
April 25th 2024While the Dynamic International Prognostic Scoring System and bone marrow blasts may predict overall survival, the lack of certain mutations is also associated with a better prognosis for myeloproliferative neoplasm, unclassifiable (MPN-U).
Read More
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More